Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
NCT Number: NCT06897137
This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions
Interested in participating?
Request Info15 year and older
All sexes
Observational
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
PRIMARY OBJECTIVES:
Secondary Objective
OUTLINE: This is an observational study.
Participants complete surveys on study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
AYAs with a cancer history (AYA-C)
Inclusion criteria
Exclusion criteria
AYAs General Population (AYA-GP)
Inclusion criteria
Caregivers of AYAs with cancer (AYA-Cg)
Inclusion criteria
Participants will complete self-report questionnaires via Redcap. The questionnaires should take less than 30 minutes and will include the following options based on their relevance to each sample: 1) sociodemographic (including the comorbidity index) and clinical information, 2) newly developed item pools for body image, fertility, and financial burden, 3) legacy measures for body image, fertility, and financial burden, 4) the PROMIS AYA Health Status Profile, and 5) the PROMIS Global.
Time frame: Up to study completion, up to approximately 2 years
Upon completion of data analysis and study team review, investigators will have four unidimensional and locally independent, calibrated item banks: three for AYAs (body image, fertility, and financial burden) and one for caregivers (financial burden). In order to successfully calibrate an item bank, an n=500 is required per bank. In order to examine differential item functioning (DIF), a minimum n=200 per group is recommended. Our proposed sample sizes and specific subgroup accrual targets will be needed to calibrate multiple new item banks (body image, fertility, financial burden), evaluate DIF for various categories (age, gender, race, education) within our sample subgroups (AYAs with and without cancer), and to conduct confirmatory factor analysis (CFAs) on the item banks. In addition, the AYA sample the general population will serve as our reference to establish the mean and standard deviation for body image and fertility.
Time frame: Up to study completion, up to approximately 2 years
After the body image, fertility, and financial burden item banks have been calibrated from the primary outcome, short forms will be assembled by selecting the most informative (i.e., high measurement precision with little measurement error) and discriminating items (i.e., item response therapy (IRT) slopes that describe how well an item discriminates among individuals at different points along the measurement continuum) from each of the calibrated item banks. The convergent validity of the new PROMIS item banks and short forms will be examined using bivariate Pearson correlations with comparable constructs.
Contact information is provided by the study sponsor or research team.
Wake Forest University Health Sciences
Other
Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology: A Promising Solution (PROMIS AYA) - Aim 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06587100
Hematologic Diseases, Hematologic Neoplasms
San Francisco, California, United States
View Trial DetailsNCT07691008
Hematologic Diseases, Hematologic Neoplasms
View Trial DetailsNCT06881108
Hematologic Diseases, Hematologic Neoplasms
Winston-Salem, North Carolina, United States
View Trial DetailsNCT05334069
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Anchorage, Alaska, United States
View Trial Details